Drug Trial Radar · NCT05224401
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
Last checked: Nov 20, 2026Latest source record: Aug 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
330
Planned (sponsor's estimate)
Start
May 29, 2023
Primary completion
Sep 1, 2027
Study completion Sep 1, 2027
Sponsor
- Lead sponsor
- Lund UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate if the combination of pivmecillinam and clavulanic acid (PAC) is non-inferior to ciprofloxacin, trimethoprim-sulfamethoxazole or ertapenem as step down oral therapy in patients with febrile UTI caused by extended spectrum beta-lactamase (ESBL) producing Enterobacterales (EPE).
Conditions
- Urinary Tract Infections
- Bacteremia
- Antibiotic Resistant Infection
Interventions
Pivmecillinam and amoxicillin/clavulanic acidDrug
1 tablet pivmecillinam 400 mg and 1 tablet Amoxicillin/clavulanic acid 875/125 mg, three times daily.
Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibilityDrug
Ciprofloxacin 500 mg twice daily, trimethoprim/sulfamethoxazole 800 mg/160 mg twice daily or ertapenem 1 g once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical cureTime frame: Clinical cure 10 days (+/- 2 days)
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Helsingborg hospital
Helsingborg, Sweden · Recruiting
Kristianstad hospital
Kristianstad, Sweden · Recruiting
Skåne University Hospital, Lund
Lund, Sweden · Recruiting
Skåne University Hospital, Malmö
Malmö, Sweden · Recruiting
Västmanland hospital Västerås
Västerås, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.